Angina
Low-dose aspirin is best choice for cutting bleeding risks
Published in Blood Weekly, October 16th, 2003
The new findings emerged from a large international clinical trial called Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE). The study tested a combination of two antiplatelet agents that help prevent blood clots: aspirin and clopidogrel. CURE participants had unstable angina.
Blood clots are a major cause of heart attacks and strokes.
The main goal of the trial was to test the effectiveness of clopidogrel and aspirin vs. aspirin alone. CURE researchers reported last year...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-10-16)
More Articles from Blood Weekly
- Drug Development
Dipeptidyl peptidase inhibitor shows promise for treatment of blood cell deficiencies - Transfusion Medicine
High MBL doses may be needed to preserve protective levels - Stem-Cell Research
SDF-1 needed for BM colonization of long-term hematopoietic stem cells - Stem-Cell Transplantation
G-CSF-primed BM autografts improve hematopoietic recovery in some cancer patients - Stem-Cell Transplantation
Gemtuzumab ozogamicin increases VOD risk in myeloablative stem cell graft recipients - Stem-Cell Transplantation
Oral sirolimus shows promise as graft-versus-host disease prophylaxis - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
